Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Y., Bisso, B
Is KLOW approved for human use
This compound is handled exclusively in controlled research settings for in vitro and pre-clinical studies, with no applications in human or veterinary medicine
PMID: 10828840 Published Research Highlights Foundational Pharmacology 1998 First selective GHSR-1a agonist characterization Raun, Hansen, Johansen, and colleagues at Novo Nordisk reported that ipamorelin stimulated pulsatile GH secretion in rats, pigs, and dogs with selectivity over ACTH/cortisol release not seen with GHRP-6 or GHRP-2 at equivalent GH-effective doses
17 investigated the effect of administering reduced GSH 600 mg via aerosolization twice daily to 14 HIV-seropositive individuals
